Showing 101 - 110 of 3,763
The National Institute for Health and Clinical Excellence (NICE) invited the manufacturer of alitretinoin (Basilea Pharmaceuticals Ltd, Basel, Switzerland) to submit evidence for the clinical and cost effectiveness of this drug for the treatment of patients with severe chronic hand eczema (CHE),...
Persistent link: https://www.econbiz.de/10008620563
Background: Recommendations in the UK suggest restricting treatment of Alzheimer's disease with cholinesterase inhibitors, on cost-effectiveness grounds, to patients with moderate cognitive decline. As the economic analyses that informed these recommendations have been the subject of debate, we...
Persistent link: https://www.econbiz.de/10008620564
Background: Previous studies of economic content in medical journal advertisements have not examined all types of economic content and have not included advertisements for medical devices. Objective: To examine trends in the economic content of medical device and pharmaceutical advertisements in...
Persistent link: https://www.econbiz.de/10008620565
Background: The primary characteristics of restless legs syndrome (RLS), including severe sleep disorders, restlessness in the evening and discomfort while at rest, have substantial impact on normal daily activities. Because of the high prevalence of RLS in the general population, it is...
Persistent link: https://www.econbiz.de/10008620566
Background: Osteoporosis is a condition marked by low bone mineral density and the deterioration of bone tissue. One of the main clinical and economic consequences of osteoporosis is skeletal fractures. Objective: To assess the healthcare and work loss costs of US patients with non-vertebral...
Persistent link: https://www.econbiz.de/10008620567
Multiple sclerosis (MS) is a disease of the CNS, typically striking adults during the primary productive time of their life. The symptoms of MS can restrict the individual's physical activity and income-earning ability, resulting in a major financial burden on the patient, family, health system...
Persistent link: https://www.econbiz.de/10008620568
Persistent link: https://www.econbiz.de/10008620569
Persistent link: https://www.econbiz.de/10009025033
This paper presents a case of parsimony and generalization in model comparisons. We submitted two versions of the same cognitive model to the Market Entry Competition (MEC), which involved four-person and two-alternative (enter or stay out) games. Our model was designed according to the...
Persistent link: https://www.econbiz.de/10009025195
This paper describes the “Bounded Memory, Inertia, Sampling and Weighting” (BI-SAW) model, which won the http://sites.google.com/site/gpredcomp/Market Entry Prediction Competition in 2010. The BI-SAW model refines the I-SAW Model (Erev et al. [1]) by adding the assumption of limited memory...
Persistent link: https://www.econbiz.de/10009025196